Abdalla Marwah, Goldsmith Jeff, Muntner Paul, Diaz Keith M, Reynolds Kristi, Schwartz Joseph E, Shimbo Daichi
Department of Medicine, Columbia University Medical Center, New York, USA;
Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, USA;
Am J Hypertens. 2016 Jan;29(1):33-8. doi: 10.1093/ajh/hpv058. Epub 2015 Apr 22.
Isolated nocturnal hypertension (INH), defined as nocturnal without daytime hypertension on ambulatory blood pressure (BP) monitoring (ABPM), has been observed to be associated with an increased risk of cardiovascular disease (CVD) events and mortality. The aim of this study was to determine the short-term reproducibility of INH.
The Improving the Detection of Hypertension Study enrolled a community-based sample of adults (N = 282) in upper Manhattan without CVD, renal failure, or treated hypertension. Each participant completed two 24-hour ABPM recordings (ABPM1: first recording and ABPM2: second recording) with a mean ± SD time interval of 33 ± 17 days between recordings. Daytime hypertension was defined as mean awake systolic/diastolic BP ≥ 135/85 mm Hg; nocturnal hypertension as mean sleep systolic/diastolic BP ≥ 120/70 mm Hg; INH as nocturnal without daytime hypertension; isolated daytime hypertension (IDH) as daytime without nocturnal hypertension; day and night hypertension (DNH) as daytime and nocturnal hypertension, and any ambulatory hypertension as having daytime and/or nocturnal hypertension.
On ABPM1, 26 (9.2%), 21 (7.4%), and 50 (17.7%) participants had INH, IDH, and DNH, respectively. On ABPM2, 24 (8.5%), 19 (6.7%), and 54 (19.1%) had INH, IDH, and DNH, respectively. The kappa statistics were 0.21 (95% confidence interval (CI) 0.04-0.38), 0.25 (95% CI 0.06-0.44), and 0.65 (95% CI 0.53-0.77) for INH, IDH, and DNH respectively; and 0.72 (95% CI 0.63-0.81) for having any ambulatory hypertension.
Our results suggest that INH and IDH are poorly reproducible phenotypes, and that ABPM should be primarily used to identify individuals with daytime hypertension and/or nocturnal hypertension.
孤立性夜间高血压(INH)定义为动态血压监测(ABPM)显示夜间高血压而日间无高血压,已观察到其与心血管疾病(CVD)事件及死亡率风险增加相关。本研究的目的是确定INH的短期可重复性。
“改善高血压检测研究”纳入了曼哈顿上城无CVD、肾衰竭或未治疗高血压的社区成年样本(N = 282)。每位参与者完成两次24小时ABPM记录(ABPM1:首次记录,ABPM2:第二次记录),两次记录之间的平均±标准差时间间隔为33±17天。日间高血压定义为清醒时平均收缩压/舒张压≥135/85 mmHg;夜间高血压定义为睡眠时平均收缩压/舒张压≥120/至70 mmHg;INH为夜间高血压而日间无高血压;孤立性日间高血压(IDH)为日间高血压而夜间无高血压;昼夜高血压(DNH)为日间和夜间均有高血压,任何动态高血压为有日间和/或夜间高血压。
在ABPM1上,分别有26名(9.2%)、21名(7.4%)和50名(17.7%)参与者患有INH、IDH和DNH。在ABPM2上,分别有24名(8.5%)、19名(6.7%)和54名(19.1%)患有INH、IDH和DNH。INH、IDH和DNH的kappa统计量分别为0.21(95%置信区间(CI)0.指04-0.3指8)、0.25(95% CI 0.06-0.44)和0.65(95% CI 0.53-0.77);有任何动态高血压的kappa统计量为0.72(95% CI 0.63-0.81)。
我们的结果表明,INH和IDH是可重复性较差的表型,ABPM应主要用于识别有日间高血压和/或夜间高血压的个体。